SLC7A11 and cancer: TNBC currently as only chemotherapy as its treatment option due to the absence of growth in response to hormones and SLC7A11 is found to modulate chemotherapy or vice versa.35,36 Cancer cells are rendered more resistant to chemotherapy if SLC7A11 is overexpressed.37 This supports the fact that SLC7A11 can represent itself as a potential target to observe it as a treatment response factor in TNBC and such suggestions were backed by earlier studies.25,35,38